UMIN-CTR Clinical Trial

Unique ID issued by UMIN C000000039
Receipt number R000000079
Scientific Title A phase I/II study of uterine artery embolization using gelatine sponge for symptomatic uterine leiomyoma (JIVROSG-0302)
Date of disclosure of the study information 2005/08/05
Last modified on 2012/09/21 13:18:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A phase I/II study of uterine artery embolization using gelatine sponge for symptomatic uterine leiomyoma (JIVROSG-0302)

Acronym

Uterine artery embolization using gelatine sponge for uterine leiomyoma (JIVROSG-0302)

Scientific Title

A phase I/II study of uterine artery embolization using gelatine sponge for symptomatic uterine leiomyoma (JIVROSG-0302)

Scientific Title:Acronym

Uterine artery embolization using gelatine sponge for uterine leiomyoma (JIVROSG-0302)

Region

Japan


Condition

Condition

Symptomatic uterine leimoyoma

Classification by specialty

Obstetrics and Gynecology Radiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the safety and efficacy of uterine artery embolization using gelatine sponge in patients with symptomatic uterine leiomyoma.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Phase I,II


Assessment

Primary outcomes

Adverse events

Key secondary outcomes

Improvement of symptoms, decrease of the volume of leiomyoma, changes in ovarian function, length of hospital stay.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Bilateral uterine arteries are embolized with gelatine sponge particles using microcatheter system inserted by Seldinger's technique. The embolization is terminated when the stasis of blood flow in the ascending branch of uterine arteries is observed.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

1) Symptomatic uterine leiomyomas confirmed by imaging studies with MRI or US.
2) Uncontrolled symptoms with medical therapies.
3) Premenopausal.
4) Adecuate cardiac, hepatic, renal, respiratory, and bone marrow functions.
5) Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1.
6) Written informed consent.

Key exclusion criteria

1) Pregnant, nursing, or desiring future pregnancy.
2) Active pelvic inflammatory disease.
3) Pelvic malignancy.
4) Previous hormonal therapy within 12 weeks.
5) Contraindication to MRI.
6) Contraindication to iodized contrast material.
7) Uncontrolled cardiac, respiratory, gastrointestinal, or nervous disorders. Uncontrolled diabetes, hypertension, or infection.
8) Adenomyosis confirmed with MRI.

Target sample size

33


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Miyuki Sone

Organization

Iwate Medical University

Division name

Department of Radiology

Zip code


Address

19-1, Uchimaru, Morioka 020-8505, Japan

TEL

019-651-5111

Email



Public contact

Name of contact person

1st name
Middle name
Last name Yasuaki Arai

Organization

JIVROSG, Coordinating Office

Division name

Division of Diagnostic Radiology, National Cancer Center Hospital

Zip code


Address

5-1-1,Tsukiji,Chuo-ku,Tokyo,104-0045,Japan

TEL

03-3542-2511

Homepage URL

http://jivrosg.umin.jp/

Email

jivrosgoffice@ml.res.ncc.go.jp


Sponsor or person

Institute

Japan Interventional Radiology in Oncology Study Group (JIVROSG)

Institute

Department

Personal name



Funding Source

Organization

Ministry of Health, Labour and Welfare

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2005 Year 08 Month 05 Day


Related information

URL releasing protocol

http://jivrosg.umin.jp/

Publication of results

Published


Result

URL related to results and publications

http://www.ncbi.nlm.nih.gov/pubmed/20884240

Number of participants that the trial has enrolled


Results

-Technical success was achieved in all patients.
-Median follow-up period was 33 months.
-Minor AEs occurred in 10 pts (33%) and major AEs in two (6%). The most common AE was transient amenorrhea.
-Median hospital stay was five days.
-The rates of symptom improvement at 12 months were: menorrhagia, 90%; pelvic pain,77%;bulk-related symptoms, 96%.
-The mean reduction rate in leiomyoma volume on MRI at 12 month was 61%.

: Presented at SIR 2008, Washington D.C.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2004 Year 02 Month 15 Day

Date of IRB


Anticipated trial start date

2004 Year 03 Month 01 Day

Last follow-up date

2007 Year 07 Month 01 Day

Date of closure to data entry

2007 Year 10 Month 01 Day

Date trial data considered complete

2007 Year 10 Month 01 Day

Date analysis concluded

2007 Year 12 Month 01 Day


Other

Other related information



Management information

Registered date

2005 Year 08 Month 05 Day

Last modified on

2012 Year 09 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000079


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name